SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

SAN

81.9

+0.05%↑

MRK1

120.45

+0.67%↑

SHL.DE

44.51

-0.65%↓

ARGX

717

-0.83%↓

FRE

48.76

+0.52%↑

Kodu・Aktsiate loetelu・Pharming Group NV

P
Pharming Group NV

Suletud

1.441 -0.48

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.418

Max

1.445

Põhinäitajad
By Trading Economics
Sissetulek	2.9M 7.5M
Müük	4.1M 97M
Aktsiakasum	0.009
Kasumimarginaal	7.758
Töötajad	404

Turustatistika
By TradingEconomics
Turukapital	24M 1B
Eelmine avamishind	1.92
Eelmine sulgemishind	1.441

Pharming Group NV Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. dets 2025, 21:41 UTC

Omandamised, ülevõtmised, äriostud

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24. dets 2025, 14:57 UTC

Omandamised, ülevõtmised, äriostud

Accenture to Acquire Cabel Industry from Fibonacci Group

24. dets 2025, 12:48 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

24. dets 2025, 12:21 UTC

Suurimad hinnamuutused turgudel

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

24. dets 2025, 22:22 UTC

Omandamised, ülevõtmised, äriostud

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24. dets 2025, 21:26 UTC

Omandamised, ülevõtmised, äriostud

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24. dets 2025, 19:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24. dets 2025, 19:35 UTC

Market Talk

Treasury Yields Decline Ahead of Christmas -- Market Talk

24. dets 2025, 19:09 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

24. dets 2025, 19:09 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24. dets 2025, 19:06 UTC

Market Talk

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24. dets 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24. dets 2025, 17:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

24. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

24. dets 2025, 17:08 UTC

Omandamised, ülevõtmised, äriostud

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24. dets 2025, 16:53 UTC

Omandamised, ülevõtmised, äriostud

Nike Climb Boosts Dow, S&P 500 -- WSJ

24. dets 2025, 16:31 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24. dets 2025, 16:28 UTC

Omandamised, ülevõtmised, äriostud

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24. dets 2025, 16:17 UTC

Market Talk

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24. dets 2025, 15:33 UTC

Omandamised, ülevõtmised, äriostud

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24. dets 2025, 15:30 UTC

Omandamised, ülevõtmised, äriostud

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24. dets 2025, 15:19 UTC

Omandamised, ülevõtmised, äriostud

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24. dets 2025, 14:49 UTC

Omandamised, ülevõtmised, äriostud

Mexico's Ollamani Sells Stake in Azteca Stadium

24. dets 2025, 14:19 UTC

Market Talk

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24. dets 2025, 14:08 UTC

Omandamised, ülevõtmised, äriostud

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24. dets 2025, 14:06 UTC

Market Talk

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24. dets 2025, 13:24 UTC

Market Talk

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24. dets 2025, 12:59 UTC

Omandamised, ülevõtmised, äriostud

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24. dets 2025, 12:51 UTC

Omandamised, ülevõtmised, äriostud

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

24. dets 2025, 12:38 UTC

Omandamised, ülevõtmised, äriostud

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Pharming Group NV Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Pharming Group NV aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.